Literature DB >> 22109660

Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Ryan N Serio1.   

Abstract

Ovarian epithelial carcinomas are heterogeneous malignancies exhibiting great diversity in histological phenotypes as well as genetic and epigenetic aberrations. A general early event in tumorigenesis is regional dissemination into the peritoneal cavity. Initial spread to the peritoneum is made possible by cooperative signaling between a wide array of molecules constituting the tissue microenvironment in the coelomic epithelium. Changes in the activity of key microenvironmental components not constitutively expressed in normal tissue, including several disclosed adhesion molecules, growth factors, proteases, and G-protein coupled receptors (GPCRs), coordinate the transition. Remodeling of the extracellular matrix (ECM) and subsequent cell surface interactions enable transformation by promoting chromosomal instability (CIN) and stimulating several common signal transduction cascades to prepare the tissue for harboring and facilitating growth, angiogenesis and metastasis of the developing tumor.

Entities:  

Year:  2011        PMID: 22109660      PMCID: PMC3399066          DOI: 10.1007/s12307-011-0092-5

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  135 in total

1.  Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.

Authors:  V Samanna; H Wei; D Ego-Osuala; M A Chellaiah
Journal:  Exp Cell Res       Date:  2006-04-24       Impact factor: 3.905

Review 2.  Unraveling signalling cascades for the Snail family of transcription factors.

Authors:  Bram De Craene; Frans van Roy; Geert Berx
Journal:  Cell Signal       Date:  2005-05       Impact factor: 4.315

3.  HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.

Authors:  Keishi Narita; Julie Staub; Jeremy Chien; Kristy Meyer; Maret Bauer; Andreas Friedl; Sundaram Ramakrishnan; Viji Shridhar
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

4.  The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.

Authors:  Kwai Wa Cheng; John P Lahad; Wen-Lin Kuo; Anna Lapuk; Kyosuke Yamada; Nelly Auersperg; Jinsong Liu; Karen Smith-McCune; Karen H Lu; David Fishman; Joe W Gray; Gordon B Mills
Journal:  Nat Med       Date:  2004-10-24       Impact factor: 53.440

5.  Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth.

Authors:  A Bagnato; D Salani; V Di Castro; J R Wu-Wong; R Tecce; M R Nicotra; A Venuti; P G Natali
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

6.  A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth.

Authors:  K K Wary; A Mariotti; C Zurzolo; F G Giancotti
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

7.  Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

Authors:  Michael S Anglesio; Jeremy M Arnold; Joshy George; Anna V Tinker; Richard Tothill; Nic Waddell; Lisa Simms; Bianca Locandro; Sian Fereday; Nadia Traficante; Peter Russell; Raghwa Sharma; Michael J Birrer; Anna deFazio; Georgia Chenevix-Trench; David D L Bowtell
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

8.  Expression, regulation and function of autotaxin in thyroid carcinomas.

Authors:  Astrid Kehlen; Nadine Englert; Anja Seifert; Thomas Klonisch; Henning Dralle; Jürgen Langner; Cuong Hoang-Vu
Journal:  Int J Cancer       Date:  2004-05-10       Impact factor: 7.396

9.  E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).

Authors:  B St Croix; C Sheehan; J W Rak; V A Flørenes; J M Slingerland; R S Kerbel
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.